Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A PIK3CA mutation in Schwann cells causes severe nerve damage and increased glycolysis, but early treatment can help.

Curcuma aeruginosa Roxb. may help treat hair loss by affecting specific biological pathways.

Continued ritlecitinib treatment can lead to hair regrowth in some patients with alopecia areata who initially don't respond.

Researchers found a new mutation in the HR gene linked to a rare hair loss condition.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.

RAPK is a rare skin disorder with pigmented spots, mainly on hands and feet, starting in youth.

DKK proteins could help diagnose and treat various non-cancerous diseases.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

Rapamycin treatment helps reduce brain inflammation and symptoms of mitochondrial disease by blocking specific pathways in mice.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Oral JAK inhibitors improved alopecia areata by modulating immune responses and boosting hair growth.

Retinoids increase steroid sulfatase activity in leukemia cells through RARα/RXR and involves certain pathways like phosphoinositide 3-kinase and ERK-MAP kinase.

The STRIPAK complex is crucial for skin cell organization and creating a functional skin barrier.

Mutations in certain receptors can cause diseases and offer new treatment options.

Keratin 17 is crucial for cell growth in wound healing by aiding protein synthesis.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

Afatinib can cause eyelash and eyebrow issues, leading to eye irritation and pain.

TAK-279 effectively reduces psoriasis symptoms and is safe.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

New medicines that block a specific pathway are showing promise for treating severe hair loss but need more testing for safety and effectiveness.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

The AC 2 peptide from Trapa japonica fruit helps protect hair cells and may treat hair loss.

JAK inhibitors might help treat alopecia areata.

Axitinib treatment turned a man's grey hair back to black.

Certain tyrosine kinases may regulate hair growth and could help develop hair loss treatments.